Loading article...
Loading article...
Stream/Area:
-
Subject:
-
Paper ID:
IJSREM66375
Volume:
10 |
7 |
Jul 2026
Pages:
1-8
Publication Frequency:
Monthly (12 issues per year)
License:International Journal of Scientific Research in Engineering and Management follows the Creative Commons Attribution 4.0 (CC BY 4.0) License, allowing free use and distribution with proper attribution.
Medical science
Shri prakashchan jain college of pharmacy and research palaskhede jamner
Medical science
Shri prakashchan jain college of pharmacy and research palaskhede jamner
Medical science
Shri prakashchan jain college of pharmacy and research palaskhede jamner
Medical science
Shri prakashchan jain college of pharmacy and research palaskhede jamner
Parkinson’s disease is a common movement disorder that doctors see in neurological care, but it can be hard to diagnose and treat. The diagnosis is based on the patient's symptoms and can be tricky because people with Parkinson’s may have many motor and non-motor symptoms. Treating Parkinson’s can be difficult because there are not many drug options available, and the main treatment is levodopa. However, a common side effect of taking levodopa is called levodopa-induced dyskinesia (LID). This side effect usually happens after a long time on the medication, but sometimes it can appear even after just a few days or months. Different types of surgeries, like unilateral pallidotomy and deep brain stimulation, have worked well for people who can’t be treated effectively with medicine alone.
KEYWORDS
Parkinson's disease is a complicated brain condition that causes the nerves to slowly break down. The exact causes and ways the disease starts are not fully understood. While a small number of cases are linked to a single gene mutation, most people with Parkinson's likely don't have a specific genetic problem. Instead, the risk for the disease is probably caused by a mix of several genes that make someone more likely to develop it. Environmental factors might also play a role in increasing the chance of getting Parkinson's, although it's not clear exactly how things like smoking, drinking coffee, or being exposed to pesticides affect the disease. In terms of how the disease affects the brain, it happens because the cells that make dopamine are lost, especially in a part of the brain called the substantia nigra. Other areas of the brain can be involved too. A key sign of Parkinson's is the presence of Lewy bodies, which are clumps made mostly of a protein called alpha-synuclein. It's not clear exactly how these clumps lead to the death of brain cells. Understanding these processes could help find new ways to treat the disease and, in the future, maybe even stop it from happening.
1. Goldman SM, Tanner C. Etiology of Parkinson’s’s disease. In: Jankovic J, Tolosa E, editors. Parkinson’s’s disease and movement disorders, 3rd ed. Baltimore, MD: Lippincott-Williams and Wilkins; 1998. p. 133-58. 2. . Schrag A, Schott JM. Epidemiological, clinical, and genetic characteristics of early-onset Parkinson’sism, Lancet Neurol 2006; 5:355-63. 3. Baldereschi M, Di Carlo A, Rocca, WA, Vanni P, Maggi S, Perissinotto E, et al. Parkinson’s disease and Parkinsonism in a longitudinal study: Two-fold higher incidence in men. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 2000;55. 1358-63. 4. Van Den Eeden SK, Tanner CM, Bernstein AL, Fross RD, Leimpeter A, et al. Incidence of Parkinson’s disease: Variation by age, gender, and race/ethnicity. Am J Epidemiol 2003;157:1015-22. 5. Razdan S, Kaul RL, Motta A, Kaul S, Bhatt RK. Prevalence and pattern of major neurological disorders in rural Kashmir (India) in 1986. Neuroepidemiology 1994;13:113-9. 6. Gourie Devi M, Gururaj P, Satishchandra P. Bangalore urban and rural neurological survey. Report submitted to the Indian Council of Medical Research;1995. 7. Das SK, Sanyal K. Neuroepidemiology of major neurological disorders in rural Bengal. Neurol India 1996;49:47-58. 8. Bharucha NE, Bharucha EP, Bharucha AE, Bhise AV, Schoenberg BS. Prevalence of Parkinson’s’s disease in the Parsi community of Bombay, India. Arch Neurol 1988;45:1321-3. 9. MacPhee G. D Stewart: Parkinson's Disease. Reviews in Clinical Gerontology 11, 33-49 (/001) 10. Gazewood J, D Richards, K Clebak: Parkinson Disease An update. American Family Physician 87(4), /67-/73 (/013)
Publication Date
7/28/2026
Peer Review Type
Double-Blind Peer Review
Review Rounds: 2
Documents
Article Views
2
Total views since publication
PDF Downloads
12
Total downloads since publication
Geographic Reach
5
Digital Preservation: This article is permanently archived on Zenodo and complies with all data preservation standards across major indexing platforms.
Plagiarism Screening
This manuscript has been checked for plagiarism using TurnitinPlagiarismChecker software.
Conflict of Interest
The authors declare no conflict of interest related to this research work.
Funding Information
No funding information available for this research.
Related research in the same subject area
Loading similar articles...